Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMC vs GSK✓SelectedUSD · GSKAMC vs GSK performance historyLatest closeAs of-2.69%11/13
Stock and ETF performance explorer

AMC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-98.8%
GSK return
+105.0%
Excess return
-203.7%
Maximum drawdown
-99.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.7%+0.5%-3.2%-2.7%
7D+3.5%+1.1%+2.4%+3.4%
30D+12.5%+6.3%+6.1%+12.1%
3M+23.6%+1.8%+21.8%+23.5%
6M+144.4%+1.7%+142.7%+143.7%
YTD+108.3%+6.5%+101.8%+108.1%
1Y+38.9%+9.5%+29.4%+38.6%
3Y-58.9%+65.3%-124.2%-60.1%
5Y-99.2%+43.7%-142.9%-99.2%
All-98.8%+105.0%-203.7%-98.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling